Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

13%

1 trials in Phase 3/4

Results Transparency

33%

2 of 6 completed trials have results

Key Signals

1 recruiting2 with results

Enrollment Performance

Analytics

N/A

1(33.3%)

Phase 2

1(33.3%)

Phase 3

1(33.3%)

3Total

N/A(1)

Phase 2(1)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT07475728Not Yet Recruiting

EMS-Initiated Buprenorphine

Role: collaborator

NCT06494904Phase 3Recruiting

Standard Versus High Dose ED-Initiated Buprenorphine Induction

Role: collaborator

NCT05123027Not ApplicableCompleted

Peer Intervention to Link Overdose Survivors to Treatment (PILOT)

Role: collaborator

NCT04225598Phase 2Completed

Emergency Department-Initiated Buprenorphine Validation Network Trial

Role: collaborator

NCT03985163Completed

Patient Reported Outcomes for Opioid Use Disorder

Role: collaborator

NCT04535583Completed

Harnessing Digital Health to Understand Clinical Trajectories of Opioid Use Disorder

Role: collaborator

NCT04155502Completed

Using Social Media to Deliver HIV Self-Testing Kits and Link to Online PrEP Services

Role: collaborator

NCT02915341Completed

Towards Detecting Cocaine Use Using Smartwatches in the NIDA Clinical Trials Network

Role: collaborator

All 8 trials loaded